Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness

Moderate cognitive decline, particularly for learning and memory, was associated with Aβ+ in CN older adults in the absence of clinical disease progression and uncontrolled or serious comorbid illness.